Published in J Clin Invest on March 01, 1989
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A (1992) 5.75
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol (1994) 2.66
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.43
Genetic factors of age-related macular degeneration. Prog Retin Eye Res (2004) 2.17
Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (2009) 2.14
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest (1991) 1.64
The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein. J Neurosci (2008) 1.60
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J Clin Invest (1994) 1.54
Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron (2012) 1.46
Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A (1995) 1.40
Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis Model Mech (2012) 1.31
Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes. Clin Neurosci Res (2006) 1.24
Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci U S A (1992) 1.19
Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest (1993) 1.18
Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest (1994) 1.16
An Update on Postoperative Cognitive Dysfunction. Adv Anesth (2010) 1.12
Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest (1991) 1.12
Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord. J Proteome Res (2007) 1.11
Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis (2011) 1.09
The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci (2009) 1.04
Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E. Mol Pathol (2003) 1.02
An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury. J Pharmacol Exp Ther (2010) 1.02
Generation and function of astroglial lipoproteins from Niemann-Pick type C1-deficient mice. Biochem J (2005) 0.99
The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol (2000) 0.99
Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry (2006) 0.99
Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J Biol Chem (2009) 0.98
Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease. J Psychiatry Neurosci (1999) 0.97
Risk factors for age-related maculopathy. J Ophthalmol (2009) 0.95
Genomics of mature and immature olfactory sensory neurons. J Comp Neurol (2012) 0.94
The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages. J Cell Biol (1991) 0.94
The impact of vascular burden on late-life depression. Brain Res Rev (2009) 0.94
Regeneration-associated high level expression of apolipoprotein D mRNA in endoneurial fibroblasts of peripheral nerve. EMBO J (1990) 0.93
Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet (1994) 0.92
AR, apoE, and cognitive function. Horm Behav (2008) 0.92
Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.91
Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry (1996) 0.91
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis. J Biomed Biotechnol (2010) 0.90
Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci (1996) 0.88
Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis (2014) 0.87
Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein. Biochem J (1997) 0.87
Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease. Dement Geriatr Cogn Dis Extra (2012) 0.85
Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest (1992) 0.85
Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I? Am J Epidemiol (2007) 0.83
Cerebral lipid deposition in aged apolipoprotein-E-deficient mice. Am J Pathol (1997) 0.82
mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression. PLoS One (2014) 0.81
Apolipoprotein E gene and age-related macular degeneration in a Chinese population. Mol Vis (2011) 0.81
Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice. Neurobiol Dis (2008) 0.81
Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimers Res Ther (2015) 0.81
CSF proteomics of secondary phase spinal cord injury in human subjects: perturbed molecular pathways post injury. PLoS One (2014) 0.80
Axonal sprouting and laminin appearance after destruction of glial sheaths. Proc Natl Acad Sci U S A (1993) 0.80
Targeting cholesterol homeostasis to fight hearing loss: a new perspective. Front Aging Neurosci (2015) 0.80
Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells. J Lipid Res (2009) 0.80
MicroRNAs: a connection between cholesterol metabolism and neurodegeneration. Neurobiol Dis (2014) 0.80
BioAge: toward a multi-determined, mechanistic account of cognitive aging. Ageing Res Rev (2014) 0.79
Chronic thrombin exposure results in an increase in apolipoprotein-E levels. J Neurosci Res (2006) 0.78
Haptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines. Front Cell Neurosci (2014) 0.78
ApoE and cholesterol in schizophrenia and bipolar disorder: comparison of grey and white matter and relation with APOE genotype. J Psychiatry Neurosci (2011) 0.78
Apolipoprotein E Mimetic Promotes Functional and Histological Recovery in Lysolecithin-Induced Spinal Cord Demyelination in Mice. J Neurol Neurophysiol (2013) 0.77
Changes in CLIP3 expression after sciatic nerve injury in adult rats. J Mol Histol (2012) 0.77
Is lipoprotein (a) protective of dementia? Eur J Epidemiol (2016) 0.77
APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias. Int J Mol Epidemiol Genet (2010) 0.77
Prenatal Ethanol Exposure Up-Regulates the Cholesterol Transporters ATP-Binding Cassette A1 and G1 and Reduces Cholesterol Levels in the Developing Rat Brain. Alcohol Alcohol (2014) 0.76
Transcriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain. PLoS One (2014) 0.76
Comprehensive evaluation of the association of APOE genetic variation with plasma lipoprotein traits in U.S. whites and African blacks. PLoS One (2014) 0.76
oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages. PLoS One (2016) 0.75
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans. Sci Rep (2017) 0.75
Vascular Health and Genetic Risk Affect Mild Cognitive Impairment Status and 4-Year Stability: Evidence From the Victoria Longitudinal Study. J Gerontol B Psychol Sci Soc Sci (2015) 0.75
Lesion-induced synthesis and secretion of proteins by nonneuronal cells resident in frog peripheral nerve. Proc Natl Acad Sci U S A (1990) 0.75
Evidence for a role of nerve injury in painful intervertebral disc degeneration: A cross-sectional proteomic analysis of human cerebrospinal fluid. J Pain (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods Enzymol (1983) 12.78
Practical stereological methods for morphometric cytology. J Cell Biol (1966) 8.11
Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res (1984) 4.12
Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest (1985) 3.49
Regeneration in the mammalian peripheral nervous system. Physiol Rev (1956) 3.42
The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. J Biol Chem (1980) 3.05
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem (1987) 3.04
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem (1981) 3.02
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta (1987) 2.90
Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A (1986) 2.80
Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem (1979) 2.72
Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Natl Acad Sci U S A (1981) 2.30
Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem (1982) 2.19
Studies on vascular permeability in peripheral nerves. I. Distribution of circulating fluorescent serum albumin in normal, crushed and sectioned rat sciatic nerve. Acta Neuropathol (1966) 2.09
Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem (1979) 2.08
Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci U S A (1986) 1.98
Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro. Am J Pathol (1977) 1.60
Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. J Lipid Res (1980) 1.59
Chronic Wallerian degeneration--an in vivo and ultrastructural study. J Anat (1971) 1.55
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem (1986) 1.50
Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem (1983) 1.50
Lipoprotein uptake by neuronal growth cones in vitro. Science (1987) 1.47
Regulation of cellular sterol flux and synthesis by human serum lipoproteins. Biochim Biophys Acta (1974) 1.31
Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem (1985) 1.29
Denervated sheath cells secrete a new protein after nerve injury. Proc Natl Acad Sci U S A (1983) 1.27
Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem (1983) 1.23
Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem Biophys Res Commun (1986) 1.20
A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science (1985) 1.18
Changes in blood vessel permeability during degeneration and regeneration in peripheral nerves. Brain (1968) 1.18
Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages. J Exp Med (1983) 1.16
Isolation and characterization of the apolipoprotein E receptor from canine and human liver. J Biol Chem (1986) 1.10
Lipoproteins containing apo B extracted from human aortas. Structure and function. Ann N Y Acad Sci (1985) 1.05
LIPID CLASS AND FATTY ACID COMPOSITION OF INTACT PERIPHERAL NERVE AND DURING WALLERIAN DEGENERATION. J Am Oil Chem Soc (1965) 1.04
Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J Cell Biol (1983) 1.03
Purification of the LDL receptor. Methods Enzymol (1985) 0.97
Expression of specific sheath cell proteins during peripheral nerve growth and regeneration in mammals. J Cell Biol (1986) 0.97
Fine structural localization of cholesterol-1,2- 3 H in degenerating and regenerating mouse sciatic nerve. J Cell Biol (1972) 0.96
Reutilization of cholesterol-1,2-H3 in the regeneration of peripheral nerve. An autoradiographic study. Lab Invest (1970) 0.95
Lipid and protein changes in sciatic nerve during Wallerian degeneration. J Neurochem (1974) 0.91
Cholesterol ester in degenerating nerve: Origin of cholesterol moiety. Lipids (1966) 0.88
Preparative immobiline isoelectric focusing of plasma apolipoproteins on vertical slab gels. Anal Biochem (1985) 0.83
Ultrastructural findings on lipoproteins in vitro and in xanthomatous tissue. Histochem J (1978) 0.83
Wallerian degeneration of rat sciatic nerve. Changes in cholesteryl ester content and fatty acid composition. J Neurochem (1976) 0.82
The sequential alterations of endoneurial cholesterol and fatty acid in Wallerian degeneration and regeneration. J Neurochem (1980) 0.79
Glycogen, its chemistry and morphological appearance in the electron microscope.11. The complex formed in the selective contrast staining of glycogen. Histochem J (1975) 0.78
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res (1984) 4.12
Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis (1981) 3.74
Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis (2006) 3.59
Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem (1978) 3.57
Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta (1983) 3.54
Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest (1985) 3.49
Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science (1991) 3.42
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry (1978) 3.11
Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol (1998) 3.06
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem (1987) 3.04
Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem (1981) 3.02
Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983. J Infect Dis (1986) 3.01
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science (1994) 2.98
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta (1987) 2.90
Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J Biol Chem (1977) 2.86
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci U S A (1986) 2.80
Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem (1982) 2.71
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 2.70
Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A (1996) 2.70
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins. J Clin Invest (1979) 2.65
Human apolipoprotein E. The complete amino acid sequence. J Biol Chem (1982) 2.64
Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology (2000) 2.63
Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci U S A (1985) 2.59
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem (1980) 2.56
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis (1996) 2.55
Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis (1999) 2.44
Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem (1990) 2.42
Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis (1990) 2.41
Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc. Proc Natl Acad Sci U S A (1979) 2.40
Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J Biol Chem (1981) 2.39
Epidemiology of hepatitis E virus infection in Turkey. Lancet (1993) 2.29
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest (1980) 2.27
Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptors. J Clin Invest (1981) 2.27
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol (2001) 2.21
Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci U S A (1985) 2.16
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci (1999) 2.15
Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol (1991) 2.14
Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis (2000) 2.13
Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A (1995) 2.11
Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts. J Biol Chem (1979) 2.08
Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem (1996) 2.06
Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem (1994) 2.04
Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J Biol Chem (1980) 2.03
A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J Infect Dis (2001) 2.02
Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry (2000) 2.01
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A (2001) 2.00
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson (2006) 1.97
Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A (1982) 1.96
Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res (1980) 1.95
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A (1987) 1.93
Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem (1993) 1.92
Canine lipoproteins and atherosclerosis. II. Characterization of the plasma lipoproteins associated with atherogenic and nonatherogenic hyperlipidemia. Circ Res (1974) 1.91
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A (1998) 1.90
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res (1990) 1.90